Company: IMCR
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001671927-25-000018
Chunk: 51

Company: Immunocore Holdings plc
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 51
---
Basic weighted-average number of shares outstanding50,403,717 50,021,939 50,262,697 49,971,267 Diluted net (loss) income per share$(0.00)$0.17 $(0.11)$(0.55)Diluted weighted-average number of shares outstanding50,403,717 52,808,434 50,262,697 49,971,267 

The accompanying notes form an integral part of these condensed consolidated financial statements.

3

Table of Contents

Immunocore Holdings plc

Condensed Consolidated Statements of Shareholders’ Equity

(Unaudited) (In thousands, except share data)

Ordinary SharesDeferred SharesAdditional Paid-in  CapitalAccumulatedDeficitAccumulated Other Comprehensive (Loss) IncomeTotal Shareholders' EquitySharesAmountSharesAmountAs of December 31, 202450,064,860$135 5,793,501$1 $1,190,104 $(795,761)$(33,763)$360,716 Net income—— —— — 5,023 — 5,023 Other comprehensive income—— —— — — 673 673 Exercise of share options119,749— —— 2,551 — — 2,551 Share-based compensation expense—— —— 9,516 — — 9,516 As of March 31, 202550,184,609$135 5,793,501$1 $1,202,171 $(790,738)$(33,090)$378,479 Net loss—— —— — (10,300)— (10,300)Other comprehensive income—— —— — — 6,476 6,476 Exercise of share options187,459— —— 3,670 — — 3,670 Share-based compensation expense—— —— 10,156 — — 10,156 As of June 30, 202550,372,068$135 5,793,501$1 $1,215,997 $(801,038)$(26,614)$388,481 Net loss—— — — — (177)— (177)Other comprehensive loss—— — — — — (3,392)(3,392)Exercise of share options